pre-ipo
Stage
About
Mobia Medical develops the Vivistim® Paired VNS™ Therapy, an FDA-approved implantable device system designed to improve motor function in chronic ischemic stroke survivors with moderate to severe upper extremity impairment.
Explore Mobia Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.